138 related articles for article (PubMed ID: 17171818)
1. DNA repair by ERCC1 in non-small-cell lung cancer.
Wilcox JE
N Engl J Med; 2006 Dec; 355(24):2590; author reply 2591. PubMed ID: 17171818
[No Abstract] [Full Text] [Related]
2. DNA repair by ERCC1 in non-small-cell lung cancer.
Cecere F; Bria E; Rosell R
N Engl J Med; 2006 Dec; 355(24):2590-1; author reply 2591. PubMed ID: 17167144
[No Abstract] [Full Text] [Related]
3. ERCC1 measurements in clinical oncology.
Reed E
N Engl J Med; 2006 Sep; 355(10):1054-5. PubMed ID: 16957152
[No Abstract] [Full Text] [Related]
4. DNA repair by ERCC1 in non-small-cell lung cancer.
Grenader T; Shavit L
N Engl J Med; 2006 Dec; 355(24):2591; author reply 2591. PubMed ID: 17167936
[No Abstract] [Full Text] [Related]
5. Expression of ERCC1 and class III beta-tubulin in non-small cell lung cancer patients treated with carboplatin and paclitaxel.
Azuma K; Sasada T; Kawahara A; Takamori S; Hattori S; Ikeda J; Itoh K; Yamada A; Kage M; Kuwano M; Aizawa H
Lung Cancer; 2009 Jun; 64(3):326-33. PubMed ID: 18977553
[TBL] [Abstract][Full Text] [Related]
6. [Histoculture drug response assay guided adjuvant chemotherapy in patients with ERCC1-positive non-small cell lung cancer].
Hirai Y; Yoshimasu T; Oura S; Tamaki T; Ota F; Nakamura R; Shimizu Y; Naito K; Ota M; Miyasaka M; Okamura Y; Nakamura Y; Yasuoka H; Kodama R
Gan To Kagaku Ryoho; 2009 Apr; 36(4):611-4. PubMed ID: 19381033
[TBL] [Abstract][Full Text] [Related]
7. [ERCC1 expression and outcomes of neo-adjuvant chemotherapy in elderly patients with non-small cell lung cancer].
Li GF; Deng SJ; Weng WW; Guo G; Chen N
Nan Fang Yi Ke Da Xue Xue Bao; 2010 Sep; 30(9):2131-3. PubMed ID: 20855270
[TBL] [Abstract][Full Text] [Related]
8. Emodin enhances cisplatin-induced cytotoxicity via down-regulation of ERCC1 and inactivation of ERK1/2.
Ko JC; Su YJ; Lin ST; Jhan JY; Ciou SC; Cheng CM; Chiu YF; Kuo YH; Tsai MS; Lin YW
Lung Cancer; 2010 Aug; 69(2):155-64. PubMed ID: 19962780
[TBL] [Abstract][Full Text] [Related]
9. DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy.
Olaussen KA; Dunant A; Fouret P; Brambilla E; André F; Haddad V; Taranchon E; Filipits M; Pirker R; Popper HH; Stahel R; Sabatier L; Pignon JP; Tursz T; Le Chevalier T; Soria JC;
N Engl J Med; 2006 Sep; 355(10):983-91. PubMed ID: 16957145
[TBL] [Abstract][Full Text] [Related]
10. ERCC1 as a risk stratifier in platinum-based chemotherapy for nonsmall-cell lung cancer.
Olaussen KA; Mountzios G; Soria JC
Curr Opin Pulm Med; 2007 Jul; 13(4):284-9. PubMed ID: 17534174
[TBL] [Abstract][Full Text] [Related]
11. Testing for excision repair cross-complementing 1 in patients with non-small-cell lung cancer for chemotherapy response.
Felip E; Rosell R
Expert Rev Mol Diagn; 2007 May; 7(3):261-8. PubMed ID: 17489733
[TBL] [Abstract][Full Text] [Related]
12. [Correlation between expression of excision repair cross-complementing 1 and cisplatin sensitivity in non-small cell lung cancer].
Han XP; Zhang X
Zhonghua Yi Xue Za Zhi; 2010 Aug; 90(30):2115-8. PubMed ID: 21029626
[TBL] [Abstract][Full Text] [Related]
13. Expression of ERCC1, MSH2 and PARP1 in non-small cell lung cancer and prognostic value in patients treated with platinum-based chemotherapy.
Xie KJ; He HE; Sun AJ; Liu XB; Sun LP; Dong XJ
Asian Pac J Cancer Prev; 2014; 15(6):2591-6. PubMed ID: 24761869
[TBL] [Abstract][Full Text] [Related]
14. [Examination of ERCC1 expression in lung cancer patients treated with platinum-based chemotherapy].
Moldvay J; Pápay J; Puskás R; Furák J; Losonczy G; Matolcsy A
Magy Onkol; 2011 Jun; 55(2):105-9. PubMed ID: 21655476
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant chemotherapy for lung cancer.
Ikhlaque N; Baumann MA
N Engl J Med; 2004 Apr; 350(16):1681-3; author reply 1681-3. PubMed ID: 15084703
[No Abstract] [Full Text] [Related]
16. Adjuvant chemotherapy for lung cancer.
Feliu J; Espinosa E; Sánchez JJ
N Engl J Med; 2004 Apr; 350(16):1681-3; author reply 1681-3. PubMed ID: 15088319
[No Abstract] [Full Text] [Related]
17. Excision repair cross-complementation group 1 (ERCC1) in platinum-based treatment of non-small cell lung cancer with special emphasis on carboplatin: a review of current literature.
Vilmar A; Sørensen JB
Lung Cancer; 2009 May; 64(2):131-9. PubMed ID: 18804893
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant chemotherapy for lung cancer.
Morgan GW
N Engl J Med; 2004 Apr; 350(16):1681-3; author reply 1681-3. PubMed ID: 15088321
[No Abstract] [Full Text] [Related]
19. Adjuvant chemotherapy for lung cancer.
Sauter C
N Engl J Med; 2004 Apr; 350(16):1681-3; author reply 1681-3. PubMed ID: 15088320
[No Abstract] [Full Text] [Related]
20. Adjuvant chemotherapy for lung cancer.
Büyükçelik A; Utkan G; Yalçin B
N Engl J Med; 2004 Apr; 350(16):1681-3; author reply 1681-3. PubMed ID: 15088318
[No Abstract] [Full Text] [Related]
[Next] [New Search]